Ultra Low Iodine Loaded Spectral CT Angiography (CTA)
Primary Purpose
Peripheral Arterial Disease, Renal Insufficiency
Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Half iodine Spectral CT
Standard iodine conventional CT
Sponsored by
About this trial
This is an interventional diagnostic trial for Peripheral Arterial Disease focused on measuring Computed Tomography Angiography, Contrast Media
Eligibility Criteria
Inclusion Criteria:
- Inpatients and outpatients with kidney function (eGFR) allowing for safe administration of standard contrast dose (as calculated with the OmniVis calculator).
- Patients with clinical suspicion of disease of the aorta and/or arteries in the lower limb.
- Referral to CTA diagnosis, treatment planning or follow-up.
Exclusion Criteria:
- Iodine contrast medium allergy
- Age < 18 years
- Lack of informed consent
- Critical ischemia of the lower extremities
Sites / Locations
- Akershus University Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Half iodine - Spectral CT group
Standard iodine - Conventional CT
Arm Description
Patients receive half dosage of iodine contrast agent, and Spectral CT acquisition with Virtual Monoenergetic Images at 40 and 50 kiloelectronVolts (keV).
Patients receive standard dosage of iodine contrast agent, and conventional 120 kiloVolts (kV) polychromatic CT images
Outcomes
Primary Outcome Measures
Mean arterial attenuation
Attenuation (x-ray density) is measured in Hounsfield units (HU) digitally by placing a "region of interest" (ROI) circle in the Aorta, common iliac-, femoral- and popliteal arteries on the CT images acquired at the time of inclusion.
Secondary Outcome Measures
Subjective examination quality
Examination quality rated by interventional radiologists on a 4-point scale at the anatomic levels: aorta, common iliac, femoral, popliteal- and calf arteries.
Subjective examination quality rating scale:
(best) - Excellent: The demarcation of the vessel lumen is excellent, more than sufficient for confident diagnosis or exclusion of stenosis or occlusion.
- Good: The demarcation of the vessel lumen is sufficient for confident diagnosis or exclusion of stenosis or occlusion.
- Adequate: The demarcation of the vessel lumen is adequate for diagnosis or exclusion of stenosis or occlusion, but with limited confidence.
(worst) - Non-diagnostic: There is insufficient demarcation of the vessel lumen for diagnosis or exclusion of stenosis or occlusion.
Rate of diagnostic quality angiography
Based on measurements of attenuation in the aorta, common iliac-, femoral- and popliteal arteries. Diagnostic quality defined as arterial attenuation >200 Hounsfield units (HU)
Full Information
NCT ID
NCT05488899
First Posted
June 21, 2022
Last Updated
August 3, 2022
Sponsor
University Hospital, Akershus
Collaborators
Oslo Metropolitan University
1. Study Identification
Unique Protocol Identification Number
NCT05488899
Brief Title
Ultra Low Iodine Loaded Spectral CT Angiography (CTA)
Official Title
Ultra Low Iodine Loaded Spectral CT Angiography (CTA) of the Aorta and Lower Limb: A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
January 28, 2019 (Actual)
Primary Completion Date
October 16, 2020 (Actual)
Study Completion Date
October 16, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Akershus
Collaborators
Oslo Metropolitan University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The objectives of this study are:
Evaluation of ultra-low iodine load CTA protocols of the aorta and lower extremities.
To investigate whether dual-layer in combination with with virtual monoenergetic imaging (VMI) allows for reduction of contrast medium (CM) in CTA of the aorta and lower limbs i with sustained objective and subjective image quality parameters.
Detailed Description
CT angiography (CTA) of the aorta and the lower limb is one of the most important tools for diagnostic, evaluation of the severity of the peripheral arterial disease, decision making, treatment planning and follow-up; but usually requires the use of iodine contrast medium.
Due to the high prevalence of renal impairment (eGFR < 90 ml/min/1.73m) in the elderly hospitalized population (more than 90% among inpatients aged over 60 years) contrast-medium-induced nephropathy is a major concern in this population.
The recently introduced spectral CT technique utilizes x-rays covering a spectrum of energy-levels as opposed to conventional CT in which x-rays are set to one specific energy level.
This technology offers many possibilities, such as "boosting" the x-ray contrast effect of iodine. This improves the vascular enhancement of the contrast medium using low-energy, virtual monoenergetic imaging (VNI).
The objectives of this study are:
Evaluation of ultra-low iodine load CTA protocols of the aorta and lower extremities.
To investigate whether dual-layer in combination with with virtual monoenergetic imaging (VMI) allows for reduction of contrast medium (CM) in CTA of the aorta and lower limbs i with sustained objective and subjective image quality parameters.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peripheral Arterial Disease, Renal Insufficiency
Keywords
Computed Tomography Angiography, Contrast Media
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
RCT: Patients assigned to study or control group
Masking
Participant
Masking Description
Participants are not informed of which arm they are assigned to.
Allocation
Randomized
Enrollment
216 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Half iodine - Spectral CT group
Arm Type
Experimental
Arm Description
Patients receive half dosage of iodine contrast agent, and Spectral CT acquisition with Virtual Monoenergetic Images at 40 and 50 kiloelectronVolts (keV).
Arm Title
Standard iodine - Conventional CT
Arm Type
Active Comparator
Arm Description
Patients receive standard dosage of iodine contrast agent, and conventional 120 kiloVolts (kV) polychromatic CT images
Intervention Type
Diagnostic Test
Intervention Name(s)
Half iodine Spectral CT
Intervention Description
Patients receive half dosage of iodine contrast agent, and Spectral CT acquisition with Virtual Monoenergetic Images at 40 and 50 keV.
Intervention Type
Diagnostic Test
Intervention Name(s)
Standard iodine conventional CT
Intervention Description
Patients receive standard dosage of iodine contrast agent, and conventional 120 kv Polychromatic CT acquisition.
Primary Outcome Measure Information:
Title
Mean arterial attenuation
Description
Attenuation (x-ray density) is measured in Hounsfield units (HU) digitally by placing a "region of interest" (ROI) circle in the Aorta, common iliac-, femoral- and popliteal arteries on the CT images acquired at the time of inclusion.
Time Frame
Measured on CT images acquired at time of inclusion
Secondary Outcome Measure Information:
Title
Subjective examination quality
Description
Examination quality rated by interventional radiologists on a 4-point scale at the anatomic levels: aorta, common iliac, femoral, popliteal- and calf arteries.
Subjective examination quality rating scale:
(best) - Excellent: The demarcation of the vessel lumen is excellent, more than sufficient for confident diagnosis or exclusion of stenosis or occlusion.
- Good: The demarcation of the vessel lumen is sufficient for confident diagnosis or exclusion of stenosis or occlusion.
- Adequate: The demarcation of the vessel lumen is adequate for diagnosis or exclusion of stenosis or occlusion, but with limited confidence.
(worst) - Non-diagnostic: There is insufficient demarcation of the vessel lumen for diagnosis or exclusion of stenosis or occlusion.
Time Frame
Rated on CT images acquired at time of inclusion
Title
Rate of diagnostic quality angiography
Description
Based on measurements of attenuation in the aorta, common iliac-, femoral- and popliteal arteries. Diagnostic quality defined as arterial attenuation >200 Hounsfield units (HU)
Time Frame
Measured on images acquired at time of inclusion
Other Pre-specified Outcome Measures:
Title
Image noise
Description
Image noise was defined as the standard deviation of arterial attenuation measurements (see outcome 1) measured in HU digitally by placing a ROI on the CT-images in the aorta, common iliac-, femoral- and popliteal arteries.
Time Frame
Measured on CT-images acquired at time of inclusion
Title
Contrast to noise ratio (CNR)
Description
Contrast to noise ratio was defined as: (Arterial attenuation - Background attenuation) / Image noise
Arterial attenuation: (see outcome 1) measured in HU digitally by placing a ROI on the CT-images in the aorta, common iliac-, femoral- and popliteal arteries.
Background attenuation: defined as attenuation in muscle measured in HU digitally by placing an identical size ROI on the CT-images in muscle tissue at the same anatomical levels as the arterial measurements.
Image noise: see outcome 4
Time Frame
Measured on CT-images acquired at time of inclusion
Title
Signal to noise ratio (SNR)
Description
Signal to noise ratio was defined as: Arterial attenuation / Image noise
Arterial attenuation: (see outcome 1) measured in HU digitally by placing a ROI on the CT-images in the aorta, common iliac-, femoral- and popliteal arteries.
Image noise: see outcome 4
Time Frame
Measured on CT-images acquired at time of inclusion
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Inpatients and outpatients with kidney function (eGFR) allowing for safe administration of standard contrast dose (as calculated with the OmniVis calculator).
Patients with clinical suspicion of disease of the aorta and/or arteries in the lower limb.
Referral to CTA diagnosis, treatment planning or follow-up.
Exclusion Criteria:
Iodine contrast medium allergy
Age < 18 years
Lack of informed consent
Critical ischemia of the lower extremities
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter M Lauritzen, MD PhD
Organizational Affiliation
University Hospital, Akershus & Oslo University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Akershus University Hospital
City
Lørenskog
State/Province
Viken
ZIP/Postal Code
1478
Country
Norway
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Ultra Low Iodine Loaded Spectral CT Angiography (CTA)
We'll reach out to this number within 24 hrs